4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-051722
Options or other derivatives
- President and CEO acquired 1,800,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Culley Brian M · President and CEO
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-09-17 | Grant or award : show line 1 in the form Non-Qualified Option to Purchase Common Shares | +1,500,000 | 1,500,000 | D |
| 2018-09-17 | Grant or award : show line 2 in the form Restricted Stock Units | +200,000 | 200,000 | D |
| 2018-09-17 | Grant or award : show line 3 in the form Restricted Stock Units | +100,000 | 100,000 | D |
Loading xslF345X03/doc4.xml…